pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4281 |
Genomic Coordinates | chr5: 176629439 - 176629500 |
Description | Homo sapiens miR-4281 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4281 | ||||||||||||||||||||||||
Sequence | 35| GGGUCCCGGGGAGGGGGG |52 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | THBS2 | ||||||||||||||||||||
Synonyms | TSP2 | ||||||||||||||||||||
Description | thrombospondin 2 | ||||||||||||||||||||
Transcript | NM_003247 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on THBS2 | |||||||||||||||||||||
3'UTR of THBS2 (miRNA target sites are highlighted) |
>THBS2|NM_003247|3'UTR 1 ACAAGATTTGCTGCATTTCCGGCAATGCCCTGTGCATGCCATGGTCCCTAGACACCTCAGTTCATTGTGGTCCTTGTGGC 81 TTCTCTCTCTAGCAGCACCTCCTGTCCCTTGACCTTAACTCTGATGGTTCTTCACCTCCTGCCAGCAACCCCAAACCCAA 161 GTGCCTTCAGAGGATAAATATCAATGGAACTCAGAGATGAACATCTAACCCACTAGAGGAAACCAGTTTGGTGATATATG 241 AGACTTTATGTGGAGTGAAAATTGGGCATGCCATTACATTGCTTTTTCTTGTTTGTTTAAAAAGAATGACGTTTACATAT 321 AAAATGTAATTACTTATTGTATTTATGTGTATATGGAGTTGAAGGGAATACTGTGCATAAGCCATTATGATAAATTAAGC 401 ATGAAAAATATTGCTGAACTACTTTTGGTGCTTAAAGTTGTCACTATTCTTGAATTAGAGTTGCTCTACAATGACACACA 481 AATCCCATTAAATAAATTATAAACAAGGGTCAATTCAAATTTGAAGTAATGTTTTAGTAAGGAGAGATTAGAAGACAACA 561 GGCATAGCAAATGACATAAGCTACCGATTAACTAATCGGAACATGTAAAACAGTTACAAAAATAAACGAACTCTCCTCTT 641 GTCCTACAATGAAAGCCCTCATGTGCAGTAGAGATGCAGTTTCATCAAAGAACAAACATCCTTGCAAATGGGTGTGACGC 721 GGTTCCAGATGTGGATTTGGCAAAACCTCATTTAAGTAAAAGGTTAGCAGAGCAAAGTGCGGTGCTTTAGCTGCTGCTTG 801 TGCCGCTGTGGCGTCGGGGAGGCTCCTGCCTGAGCTTCCTTCCCCAGCTTTGCTGCCTGAGAGGAACCAGAGCAGACGCA 881 CAGGCCGGAAAAGGCGCATCTAACGCGTATCTAGGCTTTGGTAACTGCGGACAAGTTGCTTTTACCTGATTTGATGATAC 961 ATTTCATTAAGGTTCCAGTTATAAATATTTTGTTAATATTTATTAAGTGACTATAGAATGCAACTCCATTTACCAGTAAC 1041 TTATTTTAAATATGCCTAGTAACACATATGTAGTATAATTTCTAGAAACAAACATCTAATAAGTATATAATCCTGTGAAA 1121 ATATGAGGCTTGATAATATTAGGTTGTCACGATGAAGCATGCTAGAAGCTGTAACAGAATACATAGAGAATAATGAGGAG 1201 TTTATGATGGAACCTTAAATATATAATGTTGCCAGCGATTTTAGTTCAATATTTGTTACTGTTATCTATCTGCTGTATAT 1281 GGAATTCTTTTAATTCAAACGCTGAAAAGAATCAGCATTTAGTCTTGCCAGGCACACCCAATAATCAGTCATGTGTAATA 1361 TGCACAAGTTTGTTTTTGTTTTTGTTTTTTTTGTTGGTTGGTTTGTTTTTTTGCTTTAAGTTGCATGATCTTTCTGCAGG 1441 AAATAGTCACTCATCCCACTCCACATAAGGGGTTTAGTAAGAGAAGTCTGTCTGTCTGATGATGGATAGGGGGCAAATCT 1521 TTTTCCCCTTTCTGTTAATAGTCATCACATTTCTATGCCAAACAGGAACAATCCATAACTTTAGTCTTAATGTACACATT 1601 GCATTTTGATAAAATTAATTTTGTTGTTTCCTTTGAGGTTGATCGTTGTGTTGTTGTTTTGCTGCACTTTTTACTTTTTT 1681 GCGTGTGGAGCTGTATTCCCGAGACCAACGAAGCGTTGGGATACTTCATTAAATGTAGCGACTGTCAACAGCGTGCAGGT 1761 TTTCTGTTTCTGTGTTGTGGGGTCAACCGTACAATGGTGTGGGAGTGACGATGATGTGAATATTTAGAATGTACCATATT 1841 TTTTGTAAATTATTTATGTTTTTCTAAACAAATTTATCGTATAGGTTGATGAAACGTCATGTGTTTTGCCAAAGACTGTA 1921 AATATTTATTTATGTGTTCACATGGTCAAAATTTCACCACTGAAACCCTGCACTTAGCTAGAACCTCATTTTTAAAGATT 2001 AACAACAGGAAATAAATTGTAAAAAAGGTTTTCTATACATGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 7058.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000366787.3 | 3UTR | UUGGGGACCACGUGGGCAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
29 hsa-miR-4281 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT218864 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 4 | ||||||||
MIRT248841 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT452803 | PACS2 | phosphofurin acidic cluster sorting protein 2 | 2 | 2 | ||||||||
MIRT462825 | BCL3 | B-cell CLL/lymphoma 3 | 2 | 2 | ||||||||
MIRT467812 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT477707 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT490047 | PRRT2 | proline rich transmembrane protein 2 | 2 | 2 | ||||||||
MIRT491813 | ZBTB7B | zinc finger and BTB domain containing 7B | 2 | 2 | ||||||||
MIRT528905 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT534124 | SNX33 | sorting nexin 33 | 2 | 2 | ||||||||
MIRT550881 | IBA57 | IBA57 homolog, iron-sulfur cluster assembly | 2 | 2 | ||||||||
MIRT551263 | PSMG1 | proteasome assembly chaperone 1 | 2 | 2 | ||||||||
MIRT551984 | UGT2B10 | UDP glucuronosyltransferase family 2 member B10 | 2 | 2 | ||||||||
MIRT608916 | NCDN | neurochondrin | 2 | 6 | ||||||||
MIRT637226 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT644445 | ALDOC | aldolase, fructose-bisphosphate C | 2 | 2 | ||||||||
MIRT657162 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT658754 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT668304 | FOSL2 | FOS like 2, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT687548 | MLEC | malectin | 2 | 2 | ||||||||
MIRT690860 | PLEKHG2 | pleckstrin homology and RhoGEF domain containing G2 | 2 | 2 | ||||||||
MIRT697063 | PSMC4 | proteasome 26S subunit, ATPase 4 | 2 | 2 | ||||||||
MIRT700860 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT705073 | C4orf29 | abhydrolase domain containing 18 | 2 | 2 | ||||||||
MIRT713930 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT715904 | MFRP | membrane frizzled-related protein | 2 | 2 | ||||||||
MIRT716060 | SFTPB | surfactant protein B | 2 | 2 | ||||||||
MIRT716729 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT723382 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|